Robotic augmentation enterocystoplasty as a treatment for overactive bladder syndrome: Case report

Overactive bladder syndrome is a prevalent condition that significantly affects the quality of life of patients. In cases refractory to first- and second-line treatments, augmentation enterocystoplasty is considered a third-line treatment.

We present the case of a 72-year-old female patient with severe idiopathic overactive bladder syndrome refractory to all previous lines of treatment, in whom robotic augmentation enterocystoplasty was performed. The procedure showed positive results, significantly improving the patient's quality of life without relevant postoperative complications.

Augmentation enterocystoplasty is a well-established third-line treatment for refractory overactive bladder syndrome, providing significant symptom improvement, particularly with the robotic approach, which offers enhanced precision, reduced surgical trauma, and faster recovery. Some of its limitations may include limited access to robotic technology, a steep learning curve, and longer surgical times compared to open surgery. Although long-term complications like self-catheterization and metabolic changes exist, the procedure demonstrates high efficacy and patient satisfaction, reinforcing its value in appropriately selected cases.

Robotic augmentation enterocystoplasty is an effective and safe alternative in cases of refractory overactive bladder syndrome.